Antibiotice (BSE:ATB) Receivables Turnover : 0.55 (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Antibiotice Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Antibiotice's Revenue for the three months ended in Dec. 2023 was lei137.3 Mil. Antibiotice's average Accounts Receivable for the three months ended in Dec. 2023 was lei248.6 Mil. Hence, Antibiotice's Receivables Turnover for the three months ended in Dec. 2023 was 0.55.

Antibiotice Receivables Turnover Historical Data

The historical data trend for Antibiotice's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Antibiotice Receivables Turnover Chart

Antibiotice Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Receivables Turnover

Get a 7-Day Free Trial

1.31

1.22

1.40

2.04

2.73

Antibiotice Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Receivables Turnover	Get a 7-Day Free Trial															0.61	0.78	0.53	0.56	0.55

Competitive Comparison of Antibiotice's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Antibiotice's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Antibiotice's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Antibiotice's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Antibiotice's Receivables Turnover falls into.

Antibiotice Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Antibiotice's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

	Receivables Turnover (A: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2023 )	/ (	(Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )
=	600.781	/ (	(204.033	+	235.772)	/	2 )
=	600.781	/	219.9025
=	2.73

Antibiotice's Receivables Turnover for the quarter that ended in Dec. 2023 is calculated as

	Receivables Turnover (Q: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Dec. 2023 )	/ (	(Accounts Receivable (Q: Sep. 2023 )	+	Accounts Receivable (Q: Dec. 2023 ))	/	count )
=	137.349	/ (	(261.387	+	235.772)	/	2 )
=	137.349	/	248.5795
=	0.55

Antibiotice (BSE:ATB) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Antibiotice Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Antibiotice's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Antibiotice (BSE:ATB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Antibiotice SA (BSE:ATB) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Valea Lupului Street, Iasi, ROU, 707410

Website

http://www.antibiotice.ro

Antibiotice Ord is a Romania based company engaged in manufacturing generic medicines. It primarily develops and produces generic medicines for human use, veterinary medicines and active substance Nystatin. The group's generic medicines are primarily targeted at patients with infections, dermatological, cardiovascular, digestive tract diseases or diseases of the musculoskeletal system. It manufactures firm powders for solutions for injection and suspensions for injection (penicillins), capsules, tablets, suppositories and topical preparations (ointments, gels, creams).

Antibiotice (BSE:ATB) Headlines

No Headlines